Articul8 launches Bivia to bring domain-specific decision intelligence to enterprise AI agents SELLAS Life Sciences to Participate in the JMP Securities Hematology and Oncology Summit
NEW YORK, Nov. 30, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Reimbursed Access to Bylvay® (odevixibat) Approved in France for Patients with PFIC 1 & 2
BOSTON, Nov. 30, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease company…
Altamira Therapeutics Announces Launch of Bentrio in Hong Kong by its Partner Nuance Pharma
Hamilton, Bermuda, Nov. 30, 2022 (GLOBE NEWSWIRE) — Initiative is Nuance’s first step in penetrating…
Cerevance Announces Presentation of Preclinical Data During the Cold Spring Harbor Laboratory (CSHL) Neurodegenerative Diseases – Biology and Therapeutics Conference and Publication in Neuropharmacology
Presentation highlights a novel target identified for Alzheimer’s disease using Cerevance’s proprietary NETSseq platform Cerevance’s…
Oncotelic Publishes SNO 27th Annual Meeting Presentation Materials
AGOURA HILLS, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
Agios to Participate in December Investor Conference
CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pierre Fabre to Evaluate ERAS-007 and Encorafenib Combination
ERAS-007, a potential best-in-class ERK1/2 inhibitor, is being evaluated in combination with encorafenib and cetuximab…
Centessa Pharmaceuticals Announces New Chief People Officer Karen Anderson
BOSTON and LONDON, Nov. 30, 2022 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a…
Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
BOSTON, Nov. 30, 2022 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company…
AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development
AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development Data presented at CTAD 2022…
First Wave BioPharma Files Investigational New Drug Application for Enhanced Microgranule Delivery Formulation of Adrulipase
Upon IND clearance, Phase 2 clinical trial investigating adrulipase as a treatment for exocrine pancreatic…
Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference
$50 Million from Recent Financing Extends Expected Cash Runway Beyond the Expected PDUFA Action Date…
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
SEATTLE and CAMBRIDGE, United Kingdom, Nov. 30, 2022 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq:…
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
Company now focused on the development of ONCR-021, Oncorus’ lead self-amplifying RNA product candidate for…
LEX Reception launches legal reception service in Canada to give lawyers more time
Time is precious, LEX Reception gives more time to lawyers TORONTO, Nov. 30, 2022 (GLOBE…
Vanderburgh Co. Cyber Crime Task Force and Cellebrite Combine Efforts to Resolve Crimes Quicker and Exonerate the Innocent
Vanderburgh Co. Cyber Crime Task Force makes the most of grant funding to provide the best…
Faster, Smarter, More Secure – Sumo Logic Announces Support for AWS Verified Access
LAS VEGAS, Nov. 30, 2022 (GLOBE NEWSWIRE) — AWS re:Invent 2022 – Sumo Logic (NASDAQ:…
GitLab Dedicated Launches to Meet Organizations’ Complex Compliance Requirements
Provides the benefits of an enterprise DevSecOps platform – operational efficiency, reduced risk, and enhanced…
$10.97 Billion Potential Global Condom Market Could Be a Key Driver of Growth for Israeli Cannabis Technology Company BYND Cannasoft Enterprises
A patent pending Double-faceted condom to enhance sexual pleasure marks BYND Cannasoft’s entry in a…
EbixCash Wins Long-term Maharashtra State Road Transport Corporation (MSRTC) Contract Involving Electronic issuance and Online Reservation System, for an Estimated 6 Billion Passenger Tickets
EbixCash also has been Awarded Advertising Rights for Printing Advertisement on Backside of Each Ticket…